Doctor Ying Gue

Doctor Ying Gue

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Member of:

Dr Ying Gue graduated from the University of Dundee in 2012 and went onto clinical training completing my foundation years in Ninewells Hospital (Dundee) and core medical training in West of Scotland (Ayr and Paisley). In 2016, he developed his research during his years as a research fellow - assessing patients with coronary artery disease and risk stratification, utilising biomarkers of thrombosis and fibrinolysis to identify patients of varying degrees of risk to employ different pharmacotherapy tailored to their risk profile to achieve better outcomes. He completed my PhD in 2020 and returned to clinical training as a NIHR clinical lecturer with the University of Liverpool and the Liverpool Centre of Cardiovascular Sciences in 2021.

Presentations

Diurnal variation in thrombotic and fibrinolytic status in healthy volunteers

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Thrombosis, Bleeding

Session: Poster Session 2

Access

A randomised trial on modulating endogenous fibrinolysis in patients with acute coronary syndrome VaLiDate-R

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Thrombosis, Bleeding

Session: Poster Session 2

Access

Relationship between coronary stenosis severity and high shear thrombosis assessment in vitro

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Thrombosis, Bleeding

Session: Poster Session 2

Access

Diurnal Variation in thrombolytic status in patients presenting with STEMI

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Ischaemia, Infarction, Cardioprotection

Session: Poster Session 1

Access

Correlation between plasma clot properties, thrombin generation and whole blood fibrinolytic assays in patients presenting with STEMI

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Thrombosis, Platelets, and Coagulation

Session: Acute Coronary Syndromes ePosters

Access

Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis

Event: ESC CONGRESS 2019

Topic: Clinical

Session: Atrial fibrillation and oral anticoagulation 1

Access

Incidence of MINOCA in patients presenting with STEMI for PPCI- applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort

Event: ESC Congress 2018

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: MINOCA and Takotsubo in acute coronary syndromes

Access

Doctor Ying Gue

Biography

Contributor content

Diurnal variation in thrombotic and fibrinolytic status in healthy volunteers

A randomised trial on modulating endogenous fibrinolysis in patients with acute coronary syndrome VaLiDate-R

Relationship between coronary stenosis severity and high shear thrombosis assessment in vitro

Diurnal Variation in thrombolytic status in patients presenting with STEMI

Correlation between plasma clot properties, thrombin generation and whole blood fibrinolytic assays in patients presenting with STEMI

Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis

Incidence of MINOCA in patients presenting with STEMI for PPCI- applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort

This platform is supported by